Biochips Market Outlook, Trends, Analysis, and Forecast to 2025- study by Coherent Market Insights
Biochips are little laboratories that are capable of carrying out many biological operations at once. Biochips are divided into four functional categories: DNA chips, protein chips, lab-on-a-chips, and tissue and cell arrays. A microscope slide comprised of materials like glass, silicon chips, and nylon membrane, which is printed with millions of tiny spots, is what makes up DNA chips, biochips, or DNA microarrays. These locations contain a recognised gene or DNA sequence in a systematic order.
Biochips Market |
By reducing the time and expense
needed for traditional laboratory-based research methods, microfluidics and
microarray technologies have transformed the area of scientific research. When
compared to traditional laboratory methods, microfluidics has advantages such
as lower assay costs because they require a smaller sample size in nano- or
pico-liter volumes, lower labour costs, and higher sensitivity, accuracy, and
throughput. Major fields like protein function, expression profiling, drug
development, and biomarker discovery can all benefit from the use of protein
arrays.
The global Biochips Market was valued at US$ 7,026.4 million in 2016 and is expected to witness a robust CAGR of 16.2% over the forecast period (2017 – 2025).
Products built using DNA microarray, protein chip, lab-on-a-chip, and organ-on-a-chip technologies have significantly reduced time and cost constraints in their respective fields of application. Over the projected period, continued research & development into microfluidic and microarray technologies for a variety of applications is also anticipated to fuel market expansion. For instance, the Griffith Institute for Drug Discovery (GRIDD) began developing a microfluidic platform in 2017 to further cut down on the time and money needed for research.
The increasing technical advances
in biochips are the main factor driving the growth of the global biochips
market. Additionally, as customised medicine is becoming increasingly used
around the world, growing applications in cancer genomics are boosting market
growth. The expanding applications of biochips over the forecast period are
boosting the growth of the global Biochips market. However, because of the
strict regulatory requirements and the expensive price of the instruments, the
worldwide market may encounter limitations.
The Biochips Market is served by producers
including CDI Laboratories, Inc., ThermoFisher Scientific, InDevR, Inc.,
Illumina, Inc., and Randox Laboratories. HuProt Proteome Microarray, ZikaProt
(ZIKV/DENV) Proteome Microarray, Mycobacterium Tuberculosis (MTB) Proteome
Microarray, GeneChip miRNA Array, Axiom genotyping array, and BovineSNP50 v3
DNA analysis beadchip are a few examples of commercially available biochips.
Get Press Release of Biochips
Market
Comments
Post a Comment